Prof. Dirk Busch studies infection immunology with the goal of identifying therapeutically useful defense mechanisms. His work centers on antigen-specific T cells and the development of new technologies to use these cells for diagnostic and cell therapy applications.
Busch studied medicine in Mainz and Freiburg and started his clinical training and research in pediatrics in Würzburg). A German Research Foundation scholarship gave him the opportunity to work as postdoc in Prof. Eric Pamer’s laboratory at Yale University (1996 – 1999). He qualified as a lecturer and completed his residency in medical microbiology and epidemiology of infection at the Technische Universität München (TUM). Prof. Busch hosts the Institute of Advanced Study (IAS) focus group ‘Clinical Cell Processing and Purification”. He is director of the Institute for Medical Microbiology, Immunology and Hygiene at TUM since 2009. He is co-founder of STAGE cell therapeutics (now Juno therapeutics GmbH, Munich) and T Cell Factory B.V. (now Kite Pharma EU, Amsterdam).